Cure of Mammary Carcinomas in Her-2 Transgenic Mice through Sequential Stimulation of Innate (Neoadjuvant Interleukin-12) and Adaptive (DNA Vaccine Electroporation) Immunity
暂无分享,去创建一个
Piero Musiani | Federica Cavallo | Manuela Iezzi | Guido Forni | Pier-Luigi Lollini | Michela Spadaro | P. Musiani | P. Lollini | G. Forni | M. Iezzi | A. Amici | Wei-Zen Wei | C. Curcio | F. Cavallo | M. Spadaro | Emma Di Carlo | Pamela Sacchetti | Claudia Curcio | Augusto Amici | E. Di Carlo | Wei-Zen Wei | Elena Ambrosino | P. Sacchetti | E. Ambrosino
[1] G. Forni,et al. Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. , 1992, Journal of immunology.
[2] J. Ramírez,et al. Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens. , 2001, Histology and histopathology.
[3] P. Musiani,et al. A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. , 2001, Cancer research.
[4] M. Toi,et al. Anti-angiogenic therapy in breast cancer. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] W. Allum,et al. Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer? , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] L. Luistro,et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors , 1993, The Journal of experimental medicine.
[7] P. Musiani,et al. LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. , 2003, Cancer research.
[8] N. Lycke,et al. Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses. , 1999, Journal of immunology.
[9] A. Ullrich,et al. Molecular targets for breast cancer therapy and prevention , 2001, Nature Medicine.
[10] Piero Musiani,et al. Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. , 2004, Cancer research.
[11] P. Lipponen,et al. Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis , 2005, Journal of Cancer Research and Clinical Oncology.
[12] P. Musiani,et al. Interleukin 12-activated lymphocytes influence tumor genetic programs. , 2001, Cancer research.
[13] G. Trinchieri,et al. Biology of Natural Killer Cells , 1989, Advances in Immunology.
[14] J. Gratama,et al. IL-12: a promising adjuvant for cancer vaccination , 2003, Cancer Immunology, Immunotherapy.
[15] P. Musiani,et al. Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. , 2000, Cancer research.
[16] Piero Musiani,et al. DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice1 2 , 2000, The Journal of Immunology.
[17] Yao-Tseng Chen,et al. Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[18] P Signorelli,et al. Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. , 1997, Journal of the National Cancer Institute.
[19] Piero Musiani,et al. Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice , 2001, The Journal of experimental medicine.
[20] D. Kufe,et al. Induction of Antitumor Immunity by Vaccination of Dendritic Cells Transfected with MUC1 RNA1 , 2000, The Journal of Immunology.
[21] Ethan M. Shevach,et al. CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.
[22] T. Nishikawa,et al. The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer , 2003, British Journal of Cancer.
[23] Piero Musiani,et al. Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice , 1998, The Journal of experimental medicine.
[24] P. Musiani,et al. Neutrophils in anti-cancer immunological strategies: old players in new games. , 2001, Journal of hematotherapy & stem cell research.
[25] Patrick Nicolas,et al. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. , 2004, Cancer research.
[26] T. Blankenstein,et al. B cells inhibit induction of T cell-dependent tumor immunity , 1998, Nature Medicine.
[27] P. Musiani,et al. Insertion of the DNA for the 163–171 peptide of IL1β enables a DNA vaccine encoding p185neu to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice , 2001, Gene Therapy.
[28] R. Laing,et al. A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] Piero Musiani,et al. Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions. , 2004, The Journal of clinical investigation.
[30] I. Smith,et al. Is there still a role for neoadjuvant therapy in breast cancer? , 2003, Critical reviews in oncology/hematology.
[31] P. Musiani,et al. Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[32] G. Trinchieri,et al. Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.
[33] P. Musiani,et al. Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12. , 1999, Cancer research.